Fintel reports that on February 6, 2025, William Blair initiated coverage of Mersana Therapeutics (NasdaqGS:MRSN) with a ...

Fintel reports that on February 5, 2025, William Blair upgraded their outlook for Tempur Sealy International (NYSE:TPX) from ...

Research analysts at William Blair issued their Q2 2026 earnings per share (EPS) estimates for Twist Bioscience in a report ...

Equities researchers at William Blair dropped their Q2 2025 earnings per share estimates for STMicroelectronics in a report released on Monday, February 3rd. William Blair analyst J. Dorsheimer now ...

WJCC Schools last changed the name of one of its schools in 2017. Before it was Laurel Lane Elementary, the elementary school ...

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...

According to a report by Reuters on January 23, the number of citizens in the United States applying for unemployment ...

EPS of $3.45 topped estimates, with sales rising 9.8% to $3.33 billion. 2025 guidance points to continued growth in diagnostics and biopharma.

Props to BOB GORDON, MALCOLM MCKAY, ROBERT MCDOUGALL, GORDAN RANDALL, RAY DEL BIANCO, SHAUGHN MCARTHUR, MARCEL MARCOTTE, ...